Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

Harshit Garg; Brusabhanu Nayak; Prabhjot Singh

doi:10.1016/j.eururo.2018.08.046

Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

Harshit Garg
, Brusabhanu Nayak
, Prabhjot Singh

Department of Urology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e25
Journal	European Urology
Volume	75
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2018.08.046
State	Published - Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Urology

Access to Document

10.1016/j.eururo.2018.08.046

Cite this

Garg, H., Nayak, B., & Singh, P. (2019). Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52. European Urology, 75(2), e25. https://doi.org/10.1016/j.eururo.2018.08.046

Garg, Harshit ; Nayak, Brusabhanu ; Singh, Prabhjot. / Re : Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52. In: European Urology. 2019 ; Vol. 75, No. 2. pp. e25.

@article{f92ff9042cad4e1fbdc4ec0ce18c8724,

title = "Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52",

author = "Harshit Garg and Brusabhanu Nayak and Prabhjot Singh",

year = "2019",

month = feb,

doi = "10.1016/j.eururo.2018.08.046",

language = "English (US)",

volume = "75",

pages = "e25",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "2",

}

Garg, H, Nayak, B & Singh, P 2019, 'Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52', European Urology, vol. 75, no. 2, pp. e25. https://doi.org/10.1016/j.eururo.2018.08.046

Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52. / Garg, Harshit; Nayak, Brusabhanu; Singh, Prabhjot.
In: European Urology, Vol. 75, No. 2, 02.2019, p. e25.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Re

T2 - Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

AU - Garg, Harshit

AU - Nayak, Brusabhanu

AU - Singh, Prabhjot

PY - 2019/2

Y1 - 2019/2

UR - https://www.scopus.com/pages/publications/85059509386

UR - https://www.scopus.com/pages/publications/85059509386#tab=citedBy

U2 - 10.1016/j.eururo.2018.08.046

DO - 10.1016/j.eururo.2018.08.046

M3 - Letter

C2 - 30237025

AN - SCOPUS:85059509386

SN - 0302-2838

VL - 75

SP - e25

JO - European Urology

JF - European Urology

IS - 2

ER -

Garg H, Nayak B, Singh P. Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52. European Urology. 2019 Feb;75(2):e25. doi: 10.1016/j.eururo.2018.08.046

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this